Third Rock Ventures II, L.P. Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Third Rock Ventures II, L.P..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Third Rock Ventures II, L.P.. Third Rock Ventures II, L.P. is 10% Owner in MyoKardia Inc ($MYOK) and 10% Owner in Blueprint Medicines Corp ($BPMC) and 10% Owner in Sage Therapeutics, Inc. ($SAGE) and 10% Owner in Allena Pharmaceuticals, Inc. ($ALNA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Jounce Therapeutics, Inc. ($JNCE) and 10% Owner in Revolution Medicines, Inc. ($RVMD).

Over the past year Third Rock Ventures II, L.P. has been an insider in 2 companies. The total value of shares held by Third Rock Ventures II, L.P. in these companies amounts to $76,947,442.

Third Rock Ventures II, L.P. 10% Owner
Allena Pharmaceuticals, Inc.
10% Owner
Blueprint Medicines Corp
10% Owner
Global Blood Therapeutics, Inc.
10% Owner
Jounce Therapeutics, Inc.
10% Owner
MyoKardia, Inc.
10% Owner
Revolution Medicines, Inc.
10% Owner
Sage Therapeutics, Inc.
$ 76947442 The total value of shares held by Third Rock Ventures II, L.P.
Insider Rank

Third Rock Ventures II, L.P. ranks 366 out of 350,000 insiders. Go to Insider Ranking to see more.

Latest Insider Trading Transactions of Third Rock Ventures II, L.P.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000046
Value of Sales ($)0000041,764,20841,872,981

Sentiment: All, ALNA, BPMC, GBT, JNCE, MYOK, RVMD, SAGE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 14 2021JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,500,00004,447,8295.9 M to 4.4 M (-25.22 %)
May 27 2021RVMDRevolution Medicin ...Third Rock Ventures II, L.P.10% OwnerSellS30.531,231,20437,588,658543,1131.8 M to 543.1 K (-69.39 %)
May 27 2021RVMDRevolution Medicin ...Third Rock Ventures II, L.P.10% OwnerSellS30.93135,0004,175,5501,774,3171.9 M to 1.8 M (-7.07 %)
Mar 15 2021JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,250,00006,500,3497.8 M to 6.5 M (-16.13 %)
Nov 19 2020JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerSellS7.2515,000108,7739,215,3499.2 M to 9.2 M (-0.16 %)
Nov 13 2020JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,000,00009,230,34910.2 M to 9.2 M (-9.77 %)
Mar 07 2018MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSellJ0.002,000,0000885,1042.9 M to 885.1 K (-69.32 %)
Dec 08 2017MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSellJ0.002,000,00002,885,1044.9 M to 2.9 M (-40.94 %)
Nov 06 2017ALNAAllena Pharmaceuti ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.004,629,63000
Nov 06 2017ALNAAllena Pharmaceuti ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.006,122,44800
Nov 06 2017ALNAAllena Pharmaceuti ...Third Rock Ventures II, L.P.10% OwnerBuyP14.00215,0003,010,0002,790,9642.6 M to 2.8 M (+8.35 %)
Nov 06 2017ALNAAllena Pharmaceuti ...Third Rock Ventures II, L.P.10% OwnerBuyC0.002,575,96402,575,9640 to 2.6 M
Sep 29 2017MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSellJ0.002,000,00004,885,1046.9 M to 4.9 M (-29.05 %)
Sep 27 2017MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSellS43.00400,00017,200,0006,885,1047.3 M to 6.9 M (-5.49 %)
Sep 27 2017MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSellS43.00201,4008,660,2007,285,1047.5 M to 7.3 M (-2.69 %)
Sep 12 2017MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSellS44.2520,000885,08057,65177.7 K to 57.7 K (-25.76 %)
Sep 12 2017MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSellS42.3990038,1497,486,5047.5 M to 7.5 M (-0.01 %)
Sep 12 2017MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSellS41.00200,3508,214,3507,487,4047.7 M to 7.5 M (-2.61 %)
Jun 16 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,000,00002,475,1913.5 M to 2.5 M (-28.78 %)
May 19 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,000,00003,475,1914.5 M to 3.5 M (-22.35 %)
May 19 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerGiftG0.001,7080163,996165.7 K to 164 K (-1.03 %)
May 19 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerGiftG0.0050,0000165,704215.7 K to 165.7 K (-23.18 %)
Apr 06 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellJ0.002,000,00004,475,1916.5 M to 4.5 M (-30.89 %)
Apr 03 2017MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSellJ0.00850,00007,687,7548.5 M to 7.7 M (-9.96 %)
Mar 06 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS28.7310,900313,146146,208157.1 K to 146.2 K (-6.94 %)
Mar 06 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS27.697,279201,526157,108164.4 K to 157.1 K (-4.43 %)
Mar 06 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS26.9527,115730,803164,387191.5 K to 164.4 K (-14.16 %)
Mar 06 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS25.501,000,00025,500,000285,7131.3 M to 285.7 K (-77.78 %)
Mar 06 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS25.501,000,00025,500,0006,475,1917.5 M to 6.5 M (-13.38 %)
Feb 09 2017BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerSellS35.281,000,00035,275,0004,453,7535.5 M to 4.5 M (-18.34 %)
Feb 03 2017JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.0011,250,00000
Feb 03 2017JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.0035,750,00000
Feb 03 2017JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerBuyC0.003,048,78003,048,7800 to 3 M
Feb 03 2017JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerBuyC0.009,688,344010,230,349542 K to 10.2 M (+1,787.50 %)
Dec 16 2016GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellJ0.002,000,00007,475,1919.5 M to 7.5 M (-21.11 %)
Dec 01 2016MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSellJ0.00850,00008,537,7549.4 M to 8.5 M (-9.05 %)
Nov 16 2016GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS19.361,000,00019,360,0001,285,7132.3 M to 1.3 M (-43.75 %)
Nov 16 2016GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS19.361,000,00019,360,0009,475,19110.5 M to 9.5 M (-9.55 %)
Nov 07 2016GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellJ0.002,000,000010,475,19112.5 M to 10.5 M (-16.03 %)
Aug 19 2016SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,000,00002,892,9163.9 M to 2.9 M (-25.69 %)
May 18 2016SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerSellS31.25850,00026,562,5003,892,9164.7 M to 3.9 M (-17.92 %)
Apr 15 2016BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,200,00005,453,7536.7 M to 5.5 M (-18.03 %)
Nov 18 2015BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerBuyJ0.0040,290040,2900 to 40.3 K
Nov 18 2015BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerBuyJ0.0040,290040,2900 to 40.3 K
Nov 18 2015BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerBuyJ0.0040,290040,2900 to 40.3 K
Nov 18 2015BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerSellJ0.00220,38700220.4 K to 0 (-100.00 %)
Nov 18 2015BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerBuyJ0.00220,3870220,3870 to 220.4 K
Nov 18 2015BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerSellJ0.00739,30606,653,7537.4 M to 6.7 M (-10.00 %)
Nov 13 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerBuyJ0.0015,986065,22749.2 K to 65.2 K (+32.46 %)
Nov 13 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerBuyJ0.0015,986065,22649.2 K to 65.2 K (+32.47 %)
Nov 13 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerSellJ0.00109,83200109.8 K to 0 (-100.00 %)
Nov 13 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerBuyJ0.00109,8320109,8320 to 109.8 K
Nov 13 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,700,00004,742,9166.4 M to 4.7 M (-26.39 %)
Nov 05 2015MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerOption ExerciseC0.005,500,00000
Nov 05 2015MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerOption ExerciseC0.0032,500,00000
Nov 05 2015MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerBuyC0.001,496,59801,496,5980 to 1.5 M
Nov 05 2015MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerBuyC0.008,843,53709,387,754544.2 K to 9.4 M (+1,625.00 %)
Aug 19 2015GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.0041,663,16800
Aug 19 2015GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerBuyC0.0011,903,763012,475,191571.4 K to 12.5 M (+2,083.16 %)
Aug 18 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerBuyJ0.0021,910049,24127.3 K to 49.2 K (+80.17 %)
Aug 18 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerBuyJ0.0021,910049,24027.3 K to 49.2 K (+80.17 %)
Aug 18 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerSellJ0.00150,54600150.5 K to 0 (-100.00 %)
Aug 18 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerBuyJ0.00150,5460150,5460 to 150.5 K
Aug 18 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerSellJ0.002,330,15706,442,9168.8 M to 6.4 M (-26.56 %)
Jun 22 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerBuyJ0.009,403027,33117.9 K to 27.3 K (+52.45 %)
Jun 22 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerBuyJ0.009,402027,33017.9 K to 27.3 K (+52.44 %)
Jun 22 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerSellJ0.0064,6070064.6 K to 0 (-100.00 %)
Jun 22 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerBuyJ0.0064,607064,6070 to 64.6 K
Jun 22 2015SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,000,00008,773,0739.8 M to 8.8 M (-10.23 %)
May 12 2015BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.001,328,50200
May 12 2015BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.007,833,33300
May 12 2015BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.0030,000,00000
May 12 2015BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerBuyC0.00241,54507,393,0597.2 M to 7.4 M (+3.38 %)
May 12 2015BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerBuyC0.001,424,24207,151,5145.7 M to 7.2 M (+24.87 %)
May 12 2015BPMCBlueprint Medicine ...Third Rock Ventures II, L.P.10% OwnerBuyC0.005,454,54505,727,272272.7 K to 5.7 M (+2,000.00 %)
Jul 23 2014SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.00295,19400
Jul 23 2014SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.002,499,99900
Jul 23 2014SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.0032,500,00000
Jul 23 2014SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerBuyC0.0093,712011,681,00811.6 M to 11.7 M (+0.81 %)
Jul 23 2014SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerBuyC0.00793,650011,587,29610.8 M to 11.6 M (+7.35 %)
Jul 23 2014SAGESage Therapeutics, ...Third Rock Ventures II, L.P.10% OwnerBuyC0.0010,317,457010,793,646476.2 K to 10.8 M (+2,166.67 %)

Page:   1